On-Demand Webinar Offers Guidance for Getting Started in MedComms
A recent webinar hosted by NetworkPharma.tv offers guidance for individuals interested in entering a career in the medical communications landscape. [...]
Rubenstein Talks Modern RWD, RWE in Regulatory Decision-Making
FDA Center for Devices and Radiological Health Director of Personalized Medicine Wendy Rubenstein says modern sources of real-world evidence and [...]
FDA Rejects Intercept’s OCA for NASH
The Food and Drug Administration (FDA) last month rejected Intercept Pharmaceuticals' nonalcoholic steatohepatitis (NASH) drug, creating a major delay in [...]
Opinion: Discuss Price for COVID-19 Vaccine Now, Not Later
The U.S. should begin pricing discussions for a COVID-19 vaccine before we get "stuck paying dearly for shots that the [...]
Report Explores Patient Centricity in Clinical Trials
A new report by the Economist Intelligence Unit explores the importance of expanding patient engagement in the clinical trial landscape. [...]
ICER Hosting Series on Drug Pricing During a Pandemic
The Institute for Clinical and Economic Review (ICER) is scheduled to host a three-part series focused on drug pricing during [...]
Article: Researchers Point to Germany’s Model for Purchasing Cancer Drugs
Researchers say U.S. policymakers should look to Germany's drug purchasing model to try and better align cancer drug prices with [...]
ICER Reschedules CF Meeting
The Institute for Clinical and Economic Review (ICER) has rescheduled its public meeting on cystic fibrosis treatments to Aug. 27. [...]
NPC Webinar on COVID-19 Prices Nears
The National Pharmaceutical Council's webinar on COVID-19 drug prices is less than a week away. Registration for the event remains [...]
NICE Clinical Fellow Ali Highlights Sustainability Efforts
Fizzah Ali, a medical clinical fellow at the U.K.'s National Institute for Health and Care Excellence, discusses how the Sustainability [...]
ISPOR to Host Webinar on Drug, Device Utilization Amid Pandemic
The International Society for Pharmacoeconomics and Outcomes Research is set to host a July 28 webinar highlighting the COVID-19 pandemic's [...]
Medidata, CTI Partner on Remote Trial Reviews
CTI Clinical Trial Solutions and Consulting Services is partnering with Medidata to facilitate remote monitoring and reviews for clinical trials [...]
Report: European Drug Regulatory Network Faces Uncertain, Complex Future
A new strategy produced by European regulators considers future challenges for the European drug regulatory network, The Pink Sheet reports. [...]
ICER Outlines Planned Review of High Cholesterol Treatments
The Institute for Clinical and Economic Review (ICER) in a recently-released document outlines its planned review of high cholesterol treatments. [...]
NPC, Duke-Margolis Center for Health Policy Name New Health Policy Fellow
The National Pharmaceutical Council (NPC) and Duke-Margolis Center for Health Policy recently named Salama Freed as the 2020-22 post-doctoral health [...]
IFAPP Academy, MAPS Offer Medical Affairs Course
IFAPP Academy and the Medical Affairs Professional Society (MAPS) are offering an online course for medical affairs professionals looking to [...]
Measuring Care Value
Stacey Richter, Relentless Health Value host and Aventria Health Group co-founder, discusses metrics for measuring care value in the latest [...]
Capital Rx CEO Talks Price Transparency
Capital Rx CEO A.J. Loiacono in a new Patients Rising Podcast discusses the importance of price transparency at the pharmacy [...]
Cytel COVID-19 Clinical Development Quiz
Cytel is offering a quiz for users to gauge their knowledge on the state of COVID-19 clinical development across the [...]
OptumRx’s Calabrese: Top 3 Drugs in Pipeline
OptumRx Senior Vice President and Chief Pharmacy Officer David Calabrese in a recent interview with Managed Healthcare Executive discusses the [...]
ACS Researchers Receive RWD Award
Three American Cancer Society researchers have been awarded the Real-World Data Impact Award, ACS and Flatiron Health announced this week. [...]
McClellan Stresses Need for RWE Infrastructure
Duke-Margolis' Mark McClellan tells The Pink Sheet a robust real-world evidence infrastructure is needed, and that RWE studies should be [...]
Gupta: Five Trends That Have Accelerated in 2020
Heron Therapeutics' Anita Gupta in a recent piece published on Forbes highlights five key trends that have accelerated during the [...]
Panel Discusses Provider Prospective on Value-Based Care for mBC
A recent panel discussion on AJMC's Peer Exchange discusses how providers identify value-based care opportunities for metastatic breast cancer. The [...]
ICER Posts White Paper on Alternative Pricing Policies During Pandemic
The Institute for Clinical and Economic Review (ICER) announced the release of a new white paper on alternative policies for [...]